IPQ Inside the global regulatory dialogue

FDA Warning Letter to Chinese API Firm Cites Cross-Contamination Concerns

Sep 27th, 2011

Please Log in to print the full article

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications